Ted W. Simon

Proposing a scientific confidence framework to help support the application of adverse outcome pathways for regulatory purposes

Grace Patlewicz, Ted W. Simon, J. Craig Rowlands et al. · Regulatory Toxicology and Pharmacology · 2015 · 103 citations · Full text

Riskbenefit Ratio, Regulatory Safety Science, Preventive Medicine +23

Brain biogenic amines and reproductive dominance in bumble bees ( Bombus terrestris )

Guy Bloch, Ted W. Simon, Gene E. Robinson et al. · Journal of Comparative Physiology A · 2000 · 96 citations

Biology, Insect Social Behavior, Pheromone Biochemistry +12

Development of a neurotoxic equivalence scheme of relative potency for assessing the risk of PCB mixtures

Ted W. Simon, Janice K. Britt, Robert C. James · Regulatory Toxicology and Pharmacology · 2007 · 95 citations

Neurotoxicology, Neurotoxic Equivalence Scheme, Relative Potency +9

How well can carcinogenicity be predicted by high throughput “characteristics of carcinogens” mechanistic data?

Richard A. Becker, David A. Dreier, Mary K. Manibusan et al. · Regulatory Toxicology and Pharmacology · 2017 · 51 citations · Full text

Pathology, Exposomics, Tumor Biology +16

An exposure:activity profiling method for interpreting high-throughput screening data for estrogenic activity—Proof of concept

Richard A. Becker, Katie Paul Friedman, Ted W. Simon et al. · Regulatory Toxicology and Pharmacology · 2015 · 49 citations · Full text

Gynecology, Female Reproductive Function, Estrogenic Assays +21